access_to_medicine_stage

Access to medicine

Our goal is that all people who need our medicines can benefit from them

At Roche Pharmaceuticals Switzerland, we believe that all patients should have access to the medicines they need. We are committed to bringing medicines to market as quickly as possible. More precisely, this means getting a medicine approved for Switzerland and getting it on the list of medicines reimbursed by health insurance companies.

In order to minimise the existing hurdles around access, we are looking for new innovative and sustainable solutions. We cannot do this alone. We are open to working together with other market participants to find and implement sustainable solutions for the Swiss healthcare system.

"Best practice" of a national digital initiative

Together with other pharmaceutical companies and insurance companies, we support the SmartMIP platform from Aquantic AG. SmartMIP is a digital solution that forms the interface between pharmaceutical companies and health insurance companies.  It is a widely used digital tool that enables the entire processing of individual cases (Article 71 a-d KVV) as well as pricing models of the speciality list from the request of the health insurance to the billing. SmartMIP links all market participants and facilitates communication between members.

RocheCH_WerWirSind_People_Christen
Groundbreaking advances in health care are only meaningful if they reach the people who need them.
Remo Christen Director Market Access & Health Care Affairs

We are committed to...

  • Rapid access to new medicines for patients in Switzerland
  • New pricing solutions
  • An openness to "pay-for-performance" pricing models (100% reimbursement of Roche products at the start of therapy)
  • National digital infrastructures for the implementation of pricing models
  • Support for initiatives and pilot projects that support our vision